These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 3904810

  • 21. [PUVA therapy of chronic dermatoses on the palms and soles].
    Bruynzeel DP, Boonk WJ.
    Z Hautkr; 1980 Apr 15; 55(8):523-9. PubMed ID: 6893248
    [No Abstract] [Full Text] [Related]

  • 22. Differential hepatotoxicity of two oral retinoids (etretinate and isotretinoin) in a patient with palmoplantar psoriasis.
    Vahlquist A, Lööf L, Nordlinder H, Rollman O, Vahlquist C.
    Acta Derm Venereol; 1985 Apr 15; 65(4):359-62. PubMed ID: 2413699
    [Abstract] [Full Text] [Related]

  • 23. Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial.
    Gottlieb A, Sullivan J, van Doorn M, Kubanov A, You R, Parneix A, Hugot S, Milutinovic M.
    J Am Acad Dermatol; 2017 Jan 15; 76(1):70-80. PubMed ID: 27707593
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Aphthous ulcers responding to etretinate--a case report.
    Murphy GM, Griffiths WA.
    Clin Exp Dermatol; 1989 Jul 15; 14(4):330-1. PubMed ID: 2591103
    [Abstract] [Full Text] [Related]

  • 26. Treatment of palmoplantar psoriasis with topical methoxsalen plus long-wave ultraviolet light.
    Abel EA, Goldberg LH, Farber EM.
    Arch Dermatol; 1980 Nov 15; 116(11):1257-61. PubMed ID: 7436431
    [Abstract] [Full Text] [Related]

  • 27. [Treatment of plaque psoriasis with an aromatic retinoid (etretinate)].
    Melis M.
    Rev Med Chil; 1984 Jan 15; 112(1):20-5. PubMed ID: 6377426
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Oral alitretinoin treatment in patients with palmoplantar pustulosis inadequately responding to standard topical treatment: a randomized phase II study.
    Reich K, Graff O, Mehta N.
    Br J Dermatol; 2016 Jun 15; 174(6):1277-81. PubMed ID: 26800106
    [Abstract] [Full Text] [Related]

  • 31. Epidermal Langerhans' cells in patients with pustulosis palmoplantaris treated with etretinate or etretinate + methoxsalen photochemotherapy.
    Rosén K, Jontell M, Mobacken H, Rosdahl I.
    Acta Derm Venereol; 1988 Jun 15; 68(3):218-23. PubMed ID: 2455414
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Palmoplantar pustular psoriasis unresponsive to the interleukin-1β antagonist canakinumab.
    Mansouri B, Kivelevitch D, Campa M, Menter A.
    Clin Exp Dermatol; 2016 Apr 15; 41(3):324-6. PubMed ID: 26344848
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Acitretin in the treatment of severe psoriasis: a randomized double-blind study comparing acitretin and etretinate.
    Meffert H, Sönnichsen N.
    Acta Derm Venereol Suppl (Stockh); 1989 Apr 15; 146():176-7. PubMed ID: 2532846
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis.
    Bissonnette R, Pariser DM, Wasel NR, Goncalves J, Day RM, Chen R, Sebastian M.
    J Am Acad Dermatol; 2016 Jul 15; 75(1):99-105. PubMed ID: 27021239
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.